Infineon Technologies AG (INFIN)
Budapest Stock Exchange · Hungary · prices in HUF · close of 22 Oct 2026
Key indicators
| Last close | HUF 18,386.00 |
|---|---|
| 52-week range | 12,178.00 – 31,000.00 |
| Return, 1 month / 3 months | −13.8% / −26.7% |
| Return, 1 year / 3 years | +39.0% / +66.2% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 58.4% |
| Worst drawdown (1 year) | -40.4% |
| Average daily value traded | 8.01M HUF |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Infineon Technologies is a semiconductor company based in Germany that designs and manufactures chips for power management, microcontrollers, sensors and security applications. Its products are used in vehicles, industrial equipment, household appliances and chip cards, serving automotive, industrial and consumer markets. The company supplies components that help control electric power, sense physical conditions and protect digital transactions, working with manufacturers and system developers around the world.
The shares are listed on the Budapest Stock Exchange in Hungary under the code INFIN, and the price on this page is in Hungarian forint (HUF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Infineon Technologies AG (INFIN) trades on the Budapest Stock Exchange in Hungary. It last closed at HUF 18,386.00 on 22 October 2026.
Its price-based Market X-Ray is 49 out of 100 (a weak price profile), ranking 25 of 42 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 39.0% and over the last three months it fell 26.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Budapest Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -3.2% | ||
| From 52-week high | -40.4% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -26.7% | ||
| 6-month return | 5.1% | ||
| 12-month return, skipping the last month | 61.3% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 58.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.4% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 8.01M HUF | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.4% |
|---|---|
| 1 month | −13.8% |
| 3 months | −26.7% |
| 6 months | +5.1% |
| 1 year | +39.0% |
| 3 years | +66.2% |
| 5 years | +36.6% |
Signals
| 50-day / 200-day average | 20,949.32 / 19,001.32 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 678.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Feb 2026 | HUF 132.9300 |
| 21 Feb 2025 | HUF 141.1550 |
| 26 Feb 2024 | HUF 136.3688 |
| 17 Feb 2023 | HUF 123.1120 |
| 18 Feb 2022 | HUF 96.5331 |
| 26 Feb 2021 | HUF 79.7192 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Budapest Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.